Literature DB >> 33837275

Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study.

Xing Wang1, Shiyu Lin2, Shinan Gan3, Yeqing Gu4, Ying Yang3, Qing Zhang5, Li Liu1, Ge Meng3, Zhanxin Yao3,6, Dong Zheng3, Hongmei Wu3, Shunming Zhang3, Yawen Wang3, Tingjing Zhang3, Shaomei Sun1, Qiyu Jia1, Kun Song1, Xiao-Hui Wu7, Yuntang Wu3, Kaijun Niu8,9,10,11.   

Abstract

BACKGROUND/
OBJECTIVES: High plain water intake (PWI) lowered body weight, reduced total energy intake, and increased fat oxidation and energy consumption. Because such factors are closely linked to metabolic disorders, which are the main risk factors for nonalcoholic fatty liver disease (NAFLD) onset, it was speculated that higher PWI was associated with a lower risk of NAFLD. However, no prior human studies have examined such relationship. Therefore, the purpose of this study was to evaluate the relationship between PWI and newly diagnosed NAFLD in a large-scale adult population. SUBJECTS/
METHODS: A total of 16,434 participants from 2010 to 2019 in Tianjin, China, were included in this cross-sectional study. PWI was assessed by using a validated self-administered food frequency questionnaire, and it was categorized into three subgroups for analysis: ≤3 cups/day, 4-7 cups/day, and >7 cups/day. NAFLD was diagnosed by abdominal ultrasound. Logistic regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for the relationship between PWI and NAFLD.
RESULTS: Among 16,434 participants, 20.5% (3,364) had newly diagnosed NAFLD. After controlling for demographic characteristics, lifestyle risk factors, and dietary intake, the adjusted ORs (95% CIs) for having NAFLD across PWI categories were 1.00 (reference) for ≤3 cups/day, 0.84 (0.72, 0.97) for 4-7 cups/day, and 0.77 (0.63, 0.94) for >7 cups/day in males and 1.00 (reference) for ≤3 cups/day, 1.02 (0.81, 1.27) for 4-7 cups/day, and 1.08 (0.78, 1.49) for >7 cups/day in females, respectively.
CONCLUSIONS: This study is the first to show that higher PWI is independently related to lower newly diagnosed NAFLD among males, but not females. Further studies are needed to explore the causal relationship.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 33837275     DOI: 10.1038/s41430-021-00891-9

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  41 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  How big a problem is non-alcoholic fatty liver disease?

Authors:  Quentin M Anstee; Stuart McPherson; Christopher P Day
Journal:  BMJ       Date:  2011-07-18

3.  A micro-RNA expression signature for human NAFLD progression.

Authors:  Yan Guo; Yanhua Xiong; Quanghu Sheng; Shilin Zhao; Julia Wattacheril; Charles Robb Flynn
Journal:  J Gastroenterol       Date:  2016-02-13       Impact factor: 7.527

4.  Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition.

Authors:  Valerie Sapp; Leah Gaffney; Steven F EauClaire; Randolph P Matthews
Journal:  Hepatology       Date:  2014-10-01       Impact factor: 17.425

Review 5.  Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

Authors:  Amedeo Lonardo; Stefano Ballestri; Giulio Marchesini; Paul Angulo; Paola Loria
Journal:  Dig Liver Dis       Date:  2014-11-18       Impact factor: 4.088

Review 6.  Human water needs.

Authors:  Michael N Sawka; Samuel N Cheuvront; Robert Carter
Journal:  Nutr Rev       Date:  2005-06       Impact factor: 7.110

7.  How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

Authors:  Deepak N Amarapurkar; Estsuko Hashimoto; Laurentius A Lesmana; José D Sollano; Pei-Jer Chen; Khean-Lee Goh
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

Review 8.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

9.  Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.

Authors:  D Lee Gorden; Pavlina T Ivanova; David S Myers; J Oliver McIntyre; Michael N VanSaun; J Kelly Wright; Lynn M Matrisian; H Alex Brown
Journal:  PLoS One       Date:  2011-08-09       Impact factor: 3.240

Review 10.  Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature.

Authors:  Kate Hallsworth; Leah Avery; Michael I Trenell
Journal:  Curr Gastroenterol Rep       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.